445 related articles for article (PubMed ID: 23352188)
1. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases.
Yamauchi T; Kadowaki T
Cell Metab; 2013 Feb; 17(2):185-96. PubMed ID: 23352188
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin receptors: a review of their structure, function and how they work.
Yamauchi T; Iwabu M; Okada-Iwabu M; Kadowaki T
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):15-23. PubMed ID: 24417942
[TBL] [Abstract][Full Text] [Related]
3. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
4. Regulation and function of adiponectin receptors in skeletal muscle.
Lustig Y; Hemi R; Kanety H
Vitam Horm; 2012; 90():95-123. PubMed ID: 23017713
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors.
Heiker JT; Kosel D; Beck-Sickinger AG
Biol Chem; 2010 Sep; 391(9):1005-18. PubMed ID: 20536390
[TBL] [Abstract][Full Text] [Related]
6. Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity.
Okada-Iwabu M; Iwabu M; Yamauchi T; Kadowaki T
Endocr J; 2018 Oct; 65(10):971-977. PubMed ID: 30282888
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.
Alberti L; Gilardini L; Girola A; Moro M; Cavagnini F; Invitti C
Diabetes Obes Metab; 2007 May; 9(3):344-9. PubMed ID: 17391161
[TBL] [Abstract][Full Text] [Related]
9. [Adiponectin receptor-targeted therapy for lifestyle-related diseases].
Iwabu M; Yamauchi T; Okada-Iwabu M; Kadowaki T
Clin Calcium; 2016 Mar; 26(3):413-8. PubMed ID: 26923979
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein PTB and microRNA-221 coregulate AdipoR1 translation and adiponectin signaling.
Lustig Y; Barhod E; Ashwal-Fluss R; Gordin R; Shomron N; Baruch-Umansky K; Hemi R; Karasik A; Kanety H
Diabetes; 2014 Feb; 63(2):433-45. PubMed ID: 24130336
[TBL] [Abstract][Full Text] [Related]
11. Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes.
Singh AK; Joharapurkar AA; Khan MP; Mishra JS; Singh N; Yadav M; Hossain Z; Khan K; Kumar S; Dhanesha NA; Mishra DP; Maurya R; Sharma S; Jain MR; Trivedi AK; Godbole MM; Gayen JR; Chattopadhyay N; Sanyal S
Diabetes; 2014 Oct; 63(10):3530-44. PubMed ID: 24848063
[TBL] [Abstract][Full Text] [Related]
12. ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling.
Charlton HK; Webster J; Kruger S; Simpson F; Richards AA; Whitehead JP
Biochem Biophys Res Commun; 2010 Feb; 392(2):234-9. PubMed ID: 20074551
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes.
Fang X; Sweeney G
Biochem Soc Trans; 2006 Nov; 34(Pt 5):798-801. PubMed ID: 17052201
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin receptor binding proteins--recent advances in elucidating adiponectin signalling pathways.
Buechler C; Wanninger J; Neumeier M
FEBS Lett; 2010 Oct; 584(20):4280-6. PubMed ID: 20875820
[TBL] [Abstract][Full Text] [Related]
17. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.
Li W; Tonelli J; Kishore P; Owen R; Goodman E; Scherer PE; Hawkins M
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1301-7. PubMed ID: 17213476
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties.
Almabouada F; Diaz-Ruiz A; Rabanal-Ruiz Y; Peinado JR; Vazquez-Martinez R; Malagon MM
J Biol Chem; 2013 Feb; 288(5):3112-25. PubMed ID: 23255609
[TBL] [Abstract][Full Text] [Related]
19. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
[TBL] [Abstract][Full Text] [Related]
20. Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes.
Morínigo R; Musri M; Vidal J; Casamitjana R; Delgado S; Lacy AM; Ayuso C; Gomis R; Corominola H
Obes Surg; 2006 Jun; 16(6):745-51. PubMed ID: 16756736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
